The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
Nothing Changes On Wall Street
In the past few weeks we’ve seen the markets behaving more or less as “normal” markets do. But what is normal anymore? After the financial crisis, many pundits overused the airwaves to discuss how things have changed.
But for many investors, trying to figure out the “new boss,” perhaps they should take a look at the “old boss” to borrow an analogy from the Who.
While the thought may be disturbing to many, the reality is that little has actually changed on Wall Street. Maybe the oversight is a little better, and perhaps we’ll get better risk management from our companies, but essentially – things will remain the same.
And this is a good thing.
We can stop trying to learn the “new” Wall Street language or understand the “new” landscape. Nothing’s changed. It means that we can use the same profitable strategies that we’ve used in the past right now.
Strategies like trailing stops, following insiders, takeovers and momentum trading are still very profitable. Looking at the markets this morning, we’re seeing buyouts from Adobe Systems (Nasdaq: ADBE), increasing industrial production and outrage over high executive pay.
Just what a normal market should be doing…
And normal markets can be incredibly profitable for investors of all types.
Symbols mentioned in this article: ADBE.
- Wall Street Bets on Stocks, Not Gold
- GPS Killer: Google Rules Another Roost
- Another Marvelous Move at Disney
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed